About Bioventus
Bioventus is a company based in Durham (United States) founded in 2012. The company has 930 employees. Bioventus has completed 4 acquisitions, including BioStructures, Bioness and CartiHeal. Bioventus offers products and services including StimRouter and EXOGEN.
- Headquarter Durham, United States
- Employees 930
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website bioventus.com
- Social LinkedIn X Instagram YouTube
- Legal Name Bioventus Inc.
- Annual Revenue$568.09 M (USD)-0.91as on Dec 31, 2025
- Net Profit$22.73 M (USD)0as on Dec 31, 2025
- EBITDA$105.56 M (USD)5.46as on Dec 31, 2025
- Latest Funding Round$12M (USD), Debt – Venture
Oct 2014
- InvestorsAlcentra
& 1 more
- Employee Count930
- Investments & AcquisitionsBioStructures
& 3 more
Products & Services of Bioventus
Bioventus offers a comprehensive portfolio of products and services, including StimRouter and EXOGEN.
This device is utilized for providing relief from chronic peripheral nerve pain through the delivery of electrical pulses
This system is employed for aiding bone healing and is made available to support patient recovery in orthopedic care
Apps and channels of Bioventus
its YouTube channel Bioventus has 1.31K subscribers and 30 videos.
Videos from Bioventus
The most watched videos on Bioventus's YouTube channel, Bioventus (1.31K subscribers). Click a video to play it here.
More on Bioventus.
Funding Insights of Bioventus
- Total Rounds 2
- Last Round Debt – Venture — $12M
- Investors Count 2
All 2 funding rounds of Bioventus with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2014 | $12M | Debt – Venture | – | – | |
| May 2012 | – | Seed | – | – |
2 investors in total: 2 institutional.
Investors in Bioventus
Bioventus has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Alcentra and EW Healthcare Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Growth-stage healthcare companies are invested in by EW Healthcare Partners. | – | ewhealthcare.com | New York, United States | |
Alcentra is engaged in alternative credit investment management. | – | alcentracapital.com | New York, USA |
Investor details for Bioventus
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Bioventus
196 people are tracked at Bioventus (57 in leadership, 10 in board & advisors, 129 in team); the tracked headcount is 930.
| Name | Role | Group |
|---|---|---|
Robert Claypoole | CEO | Leadership |
Anthony Doyle | General Manager, Pain And Restorative Therapies | Leadership |
Bill Gonzalez | Director Of Sales For The Northeast | Leadership |
Dan H. | Director Of Inside Sales | Leadership |
Michelle Bychowsky | Director Of Sales Pain Treatment Division | Leadership |
Mark Singleton | Senior Vice President And Chief Financial Officer | Leadership |
Kelly Bistok | Director Of Corporate Accounting | Leadership |
Jeannie Hutton | Director, Technical Accounting | Leadership |
Zeliha Uludag | Sales Director | Indirect Markets Emea, Latam & APAC | Leadership |
Christine Trogdon | Director, Organizational Effectiveness And Change Management | Leadership |
Carl Flannery | Senior Director Of Scientific Affairs | Leadership |
Sal Pantano | Director Of Electronics Engineering | Leadership |
Josh Bell | Director Of Sales, Fracture Care | Leadership |
Mike R. | Director Of Sales | Leadership |
Eric Staves | Chief Accounting Officer | Leadership |
Cary Roussel | Director Of Sales | Leadership |
Joana Starr | Director, External Reporting | Leadership |
Lance Stokes | Director Of Sales | Leadership |
Michael M. | Director Of Sales | Leadership |
Navin Bunyan | Director Of Product Development | Leadership |
176 more people are available in the full profile.
Complete people profiles for Bioventus
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Bioventus
Bioventus is a publicly listed company on the NASDAQ with ticker symbol BVS in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date11 Feb 2021
- Listed onNASDAQ: BVS
- Listed entityBioventus Inc.
- Exchange sectorHealth technology
- ISINUS09075A1088
- Share price$12.69 (-0.63% on the day) · 2026-10-08
- Market capitalisation$1.07B
- Price to earnings16.4
- EPS (diluted, trailing year)$0.78
- Volume (last session)385,610
Financials of Bioventus
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $568.1M | $22.7M | $105.6M |
| 2024 | $573.3M | -$36.1M | $100.1M |
| 2023 | $512.4M | -$156.2M | $73.4M |
| 2022 | $512.1M | -$158.7M | $52.8M |
| 2021 | $430.9M | $19.4M | $89.9M |
Detailed financial statements for Bioventus
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bioventus
Bioventus has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include BioStructures, Bioness and CartiHeal.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Implants for bone and cartilage regeneration are developed and provided. | cartiheal.com | Kfar Saba, Israel | 2009 | Aug 2021 | $315M | |
Ultrasonic surgical devices for neurosurgical, spinal, advanced wound care and general surgery | misonix.com | Farmingdale, United States | 1959 | Jul 2021 | $518M | |
Mobility aids for CNS disorders and orthopedic injuries are developed. | bioness.com | Los Angeles, United States | 2004 | Mar 2021 | $45M | |
Develop platforms in bioresorbable bone graft products | biostructures.net | Newport Beach, United States | 2009 | Nov 2015 | •••• |
Complete acquisition details for Bioventus
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Bioventus
8 dated milestones of Bioventus across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Bioventus is founded.
- Funding First funding round.
- Funding Latest funding round, Debt – Venture, of $12.0M.
- Acquisition Acquires BioStructures.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Bioness.
- Acquisition Acquires Misonix.
- Acquisition Acquires CartiHeal.
Web traffic of Bioventus
The website of Bioventus (bioventus.com) receives about 12.9K visits a month.
- Monthly visits12.9K
▼ 7.5% vs previous month
Latest news on Bioventus
Complete news archive for Bioventus
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Bioventus
10 companies that operate in the same segment as Bioventus (Orthopedics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of high-frequency spinal cord stimulation implants | 2006 | Menlo Park, California, United States | USD 154.1 M | USD 353.08 M | 1,215 | |
Prosthetic and orthotic devices are developed for individuals with disabilities. | 1919 | Duderstadt, Lower Saxony, Germany | USD 17 M | USD 1.97 B | – | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Developer of drugs for treating rare and autoimmune diseases | 2008 | Dublin, Ireland | USD 61.78 M | USD 617.41 M | – | |
Antibody-siRNA complexes are developed for cancer treatment. | 2012 | San Diego, California, United States | USD 142.54 M | USD 10.9 M | 391 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M | – | – | |
Robotic arms are provided for mobility and rehabilitation support. | 2004 | Boston, Massachusetts, United States | USD 17.21 M | USD 40.93 M | 185 | |
AI-powered drug discovery platform for various diseases | 2016 | New York, New York, United States | USD 608 M | – | – | |
Exoskeletons for medical rehabilitation and industrial productivity are provided. | 2005 | United States | USD 24.37 M | USD 71.6 M | 61 | |
Stabilization devices for healthcare are manufactured by the company. | 2005 | New York, New York, United States | USD 142.15 M | – | 43 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Bioventus
Bioventus was founded in 2012.
Bioventus is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Bioventus has 930 employees.
Annual revenue of Bioventus is $568.09M as on Dec 31, 2025.
Bioventus was founded in 2012 and is headquartered in Durham, United States. Orthobiologic and regenerative medicine products are developed and manufactured by the company within the healthcare sector. Focus is placed on therapies for musculoskeletal conditions, including bone and cartilage repair. Operations involve research, production, and distribution primarily from U.S. facilities, serving clinicians and patients worldwide through established medical channels.
Bioventus offers StimRouter and EXOGEN.
Yes, Bioventus is publicly traded on NASDAQ under the ticker symbol BVS.
Bioventus has made 4 acquisitions, including BioStructures, Bioness, and CartiHeal.
Bioventus has 2 investors. Key investors include Alcentra, and EW Healthcare Partners.
Bioventus operates through Bioventus Llc.